JYNT (The Joint) Tariff Resilience Score: 9/10 (As of Jun. 28, 2026)


JYNT The Joint Corp JYNT
63 GF Score
Price $8.52
GF Value $11.11
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is The Joint Tariff Resilience Score?

The Joint JYNT -7.49% 63 Tariff Resilience Score is 9 as of Jun. 28, 2026. GuruFocus rates JYNT with a GF Score™ of 63/100 and a GF Value™ of $11.11 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 674 Healthcare Providers & Services companies, The Joint ranks better than 99.85% on this metric.

The Joint has the Tariff Resilience Score of 9, which implies that the company might have Highly Resilient.

The Joint has The Joint Corp operates in the healthcare sector with minimal reliance on international supply chains, making it highly resilient to tariffs. Its domestic focus limits exposure to trade disruptions.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes The Joint might have Highly Resilient.

The Joint  (NAS:JYNT) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

The Joint Tariff Resilience Score Related Terms

JYNT vs MAHN, WW, PARK: Tariff Resilience Score Comparison

For the Medical Care Facilities subindustry, The Joint's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Joint Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, The Joint's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where The Joint's Tariff Resilience Score falls into.


JYNT
63GF Score
The Joint Corp JYNT
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 9 mean?
The Joint (JYNT) has a Tariff Resilience Score of 9 as of Jun. 28, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, The Joint ranks #1 out of 674 companies in the Healthcare Providers & Services industry, placing it in the top 0.099999999999994%.
Is The Joint's Tariff Resilience Score too high?
The Joint's current Tariff Resilience Score is 9. Based on the distribution chart, The Joint ranks #1 out of 674 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, The Joint has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Joint's Tariff Resilience Score compare to MAHN and WW?
According to the Healthcare Providers & Services industry distribution chart, The Joint ranks #1 out of 674 companies for Tariff Resilience Score. This places The Joint in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. The Joint's current Tariff Resilience Score is 9. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Joint stock overvalued right now?
Based on GuruFocus' analysis, The Joint (JYNT) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.11, compared to a current price of $8.52 — trading 23.3% below its estimated fair value. The current Tariff Resilience Score is 9. The Joint's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For The Joint (JYNT), the current Tariff Resilience Score is 9 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Joint (JYNT) Overvalued in 2026?

Based on GuruFocus' analysis, The Joint stock appears to be undervalued. The current stock price of $8.52 is trading 23.3% below its estimated GF Value™ of $11.11. GuruFocus considers The Joint to be Modestly Undervalued.

Key valuation signals for JYNT:

  • Tariff Resilience Score: 9
  • GF Value™: $11.11 vs. price of $8.52 (23.3% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the JYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Joint Business Description

Address 16767 North Perimeter Drive, Suite 110, Scottsdale, AZ, USA, 85260
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
63GF Score

Get the complete analysis for JYNT

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.52
Price
$11.11
GF Value